Artivion, Inc.
NYSE: AORT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- James Patrick Mackin
- Employees
- 1,600
- Headquarters
- Kennesaw, United States
- IPO year
- 1993
- Market cap
- $1.1B
- Website
- https://artivion.com
Loading AORT…
Loading profile data…Frequently asked questions about AORT
What does Artivion, Inc. (AORT) do?
Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart...
Where does AORT trade?
Artivion, Inc. (AORT) trades on the New York Stock Exchange.
What sector is AORT in?
Artivion, Inc. (AORT) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Artivion, Inc.?
James Patrick Mackin is the chief executive officer of Artivion, Inc. (AORT).
Where is Artivion, Inc. headquartered?
Artivion, Inc. is headquartered in United States.
Does AORT pay a dividend?
Artivion, Inc. (AORT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AORT go public?
Artivion, Inc. (AORT) completed its initial public offering in 1993.